Analysis of the IHC scores also revealed that the immunoreactivity score (IRS) of EZH2 staining was 1.5 for the normal cervical tissues, 3.1 for the CIS tissues and 6.6 for the cervical cancer tissues (p<0.05, Figure 1C). This evidence concerns the gene EZH2 and in situ carcinoma.